A detailed history of West Oak Capital, LLC transactions in Organon & Co. stock. As of the latest transaction made, West Oak Capital, LLC holds 22 shares of OGN stock, worth $332. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 22 -0.0%
Holding current value
$332
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

SELL
$17.45 - $21.96 $872 - $1,098
-50 Reduced 69.44%
22 $0
Q2 2023

Jul 19, 2023

SELL
$19.27 - $24.63 $578 - $738
-30 Reduced 29.41%
72 $1,000
Q1 2022

Apr 20, 2022

SELL
$30.45 - $39.36 $1,126 - $1,456
-37 Reduced 26.62%
102 $4,000
Q4 2021

Jan 12, 2022

SELL
$28.67 - $37.13 $60,092 - $77,824
-2,096 Reduced 93.78%
139 $4,000
Q3 2021

Oct 07, 2021

SELL
$28.63 - $35.64 $5,582 - $6,949
-195 Reduced 8.02%
2,235 $73,000
Q2 2021

Jul 20, 2021

BUY
$28.45 - $38.0 $69,133 - $92,340
2,430 New
2,430 $74,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.84B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track West Oak Capital, LLC Portfolio

Follow West Oak Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Oak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Oak Capital, LLC with notifications on news.